As of 2025-12-23, the Relative Valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (42.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.59 USD, the upside of Arcturus Therapeutics Holdings Inc based on Relative Valuation is -741.4%.
The range of the Relative Valuation is (30.67) - (49.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 20.9x | 17.9x |
| Forward P/E multiples | 13.1x - 25.4x | 18.1x |
| Fair Price | (30.67) - (49.17) | (42.27) |
| Upside | -565.3% - -846.1% | -741.4% |
| Date | P/E |
| 2025-12-19 | -2.78 |
| 2025-12-18 | -2.74 |
| 2025-12-17 | -2.78 |
| 2025-12-16 | -3.04 |
| 2025-12-15 | -3.09 |
| 2025-12-12 | -3.18 |
| 2025-12-11 | -3.20 |
| 2025-12-10 | -3.27 |
| 2025-12-09 | -3.07 |
| 2025-12-08 | -3.17 |
| 2025-12-05 | -3.04 |
| 2025-12-04 | -2.91 |
| 2025-12-03 | -2.81 |
| 2025-12-02 | -2.66 |
| 2025-12-01 | -2.76 |
| 2025-11-28 | -2.89 |
| 2025-11-26 | -2.90 |
| 2025-11-25 | -2.90 |
| 2025-11-24 | -2.70 |
| 2025-11-21 | -2.67 |
| 2025-11-20 | -2.51 |
| 2025-11-19 | -2.57 |
| 2025-11-18 | -2.82 |
| 2025-11-17 | -2.88 |
| 2025-11-14 | -3.10 |
| 2025-11-13 | -3.31 |
| 2025-11-12 | -3.46 |
| 2025-11-11 | -3.69 |
| 2025-11-10 | -3.74 |
| 2025-11-07 | -3.71 |
| 2025-11-06 | -3.53 |
| 2025-11-05 | -3.68 |
| 2025-11-04 | -3.80 |
| 2025-11-03 | -3.96 |
| 2025-10-31 | -4.25 |
| 2025-10-30 | -4.10 |
| 2025-10-29 | -4.02 |
| 2025-10-28 | -4.21 |
| 2025-10-27 | -4.51 |
| 2025-10-24 | -4.78 |
| 2025-10-23 | -5.11 |
| 2025-10-22 | -4.91 |
| 2025-10-21 | -9.86 |
| 2025-10-20 | -9.16 |
| 2025-10-17 | -8.80 |
| 2025-10-16 | -9.25 |
| 2025-10-15 | -9.19 |
| 2025-10-14 | -9.05 |
| 2025-10-13 | -8.26 |
| 2025-10-10 | -8.07 |